nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefdinir—MPO—atherosclerosis	0.56	1	CbGaD
Cefdinir—SLC22A5—Niacin—atherosclerosis	0.22	1	CbGbCtD
Cefdinir—MPO—superior mesenteric artery—atherosclerosis	0.038	0.693	CbGeAlD
Cefdinir—Microscopic hematuria—Rosuvastatin—atherosclerosis	0.0112	0.0935	CcSEcCtD
Cefdinir—MPO—artery—atherosclerosis	0.00406	0.0741	CbGeAlD
Cefdinir—Abnormal faeces—Pravastatin—atherosclerosis	0.00382	0.0317	CcSEcCtD
Cefdinir—MPO—endothelium—atherosclerosis	0.00343	0.0626	CbGeAlD
Cefdinir—Nephropathy—Rosuvastatin—atherosclerosis	0.0032	0.0266	CcSEcCtD
Cefdinir—MPO—blood vessel—atherosclerosis	0.00316	0.0577	CbGeAlD
Cefdinir—Interstitial lung disease—Ezetimibe—atherosclerosis	0.00179	0.0149	CcSEcCtD
Cefdinir—Laryngeal oedema—Niacin—atherosclerosis	0.00173	0.0144	CcSEcCtD
Cefdinir—Rhabdomyolysis—Rosuvastatin—atherosclerosis	0.00172	0.0143	CcSEcCtD
Cefdinir—Interstitial lung disease—Simvastatin—atherosclerosis	0.0017	0.0142	CcSEcCtD
Cefdinir—Peptic ulcer—Niacin—atherosclerosis	0.00166	0.0138	CcSEcCtD
Cefdinir—MPO—connective tissue—atherosclerosis	0.00162	0.0296	CbGeAlD
Cefdinir—Interstitial lung disease—Pravastatin—atherosclerosis	0.00154	0.0128	CcSEcCtD
Cefdinir—Cholestasis—Niacin—atherosclerosis	0.00146	0.0121	CcSEcCtD
Cefdinir—Rhabdomyolysis—Lovastatin—atherosclerosis	0.00146	0.0121	CcSEcCtD
Cefdinir—Rhabdomyolysis—Ezetimibe—atherosclerosis	0.00143	0.0119	CcSEcCtD
Cefdinir—MPO—cardiovascular system—atherosclerosis	0.00141	0.0258	CbGeAlD
Cefdinir—Rhabdomyolysis—Simvastatin—atherosclerosis	0.00136	0.0113	CcSEcCtD
Cefdinir—Cefazolin—PON1—atherosclerosis	0.00135	0.556	CrCbGaD
Cefdinir—Rhabdomyolysis—Niacin—atherosclerosis	0.00125	0.0104	CcSEcCtD
Cefdinir—Rhabdomyolysis—Pravastatin—atherosclerosis	0.00123	0.0103	CcSEcCtD
Cefdinir—Hepatic failure—Rosuvastatin—atherosclerosis	0.00123	0.0102	CcSEcCtD
Cefdinir—Renal failure acute—Rosuvastatin—atherosclerosis	0.0012	0.00995	CcSEcCtD
Cefdinir—Vaginal inflammation—Niacin—atherosclerosis	0.00111	0.00922	CcSEcCtD
Cefdinir—Hepatic function abnormal—Lovastatin—atherosclerosis	0.00107	0.00891	CcSEcCtD
Cefdinir—MPO—IL23-mediated signaling events—IL17A—atherosclerosis	0.00105	0.0247	CbGpPWpGaD
Cefdinir—Vaginal infection—Niacin—atherosclerosis	0.00105	0.0087	CcSEcCtD
Cefdinir—Hepatic failure—Lovastatin—atherosclerosis	0.00104	0.00867	CcSEcCtD
Cefdinir—Haemolytic anaemia—Lovastatin—atherosclerosis	0.00104	0.00863	CcSEcCtD
Cefdinir—Hepatic failure—Ezetimibe—atherosclerosis	0.00102	0.0085	CcSEcCtD
Cefdinir—Rash maculo-papular—Niacin—atherosclerosis	0.00101	0.00838	CcSEcCtD
Cefdinir—Hepatic function abnormal—Simvastatin—atherosclerosis	0.001	0.00834	CcSEcCtD
Cefdinir—Hepatic failure—Simvastatin—atherosclerosis	0.000975	0.00811	CcSEcCtD
Cefdinir—Purpura—Lovastatin—atherosclerosis	0.000971	0.00808	CcSEcCtD
Cefdinir—Haemolytic anaemia—Simvastatin—atherosclerosis	0.00097	0.00807	CcSEcCtD
Cefdinir—SLC15A1—liver—atherosclerosis	0.00097	0.0177	CbGeAlD
Cefdinir—Hepatic function abnormal—Niacin—atherosclerosis	0.00092	0.00765	CcSEcCtD
Cefdinir—Purpura—Simvastatin—atherosclerosis	0.000909	0.00756	CcSEcCtD
Cefdinir—Hepatic function abnormal—Pravastatin—atherosclerosis	0.000906	0.00754	CcSEcCtD
Cefdinir—MPO—C-MYB transcription factor network—CSF1R—atherosclerosis	0.000886	0.0207	CbGpPWpGaD
Cefdinir—MPO—Vitamin B12 Metabolism—LDLR—atherosclerosis	0.000881	0.0206	CbGpPWpGaD
Cefdinir—Hepatic failure—Pravastatin—atherosclerosis	0.000881	0.00733	CcSEcCtD
Cefdinir—Haemolytic anaemia—Pravastatin—atherosclerosis	0.000877	0.0073	CcSEcCtD
Cefdinir—MPO—liver—atherosclerosis	0.000872	0.0159	CbGeAlD
Cefdinir—Renal failure acute—Pravastatin—atherosclerosis	0.000858	0.00713	CcSEcCtD
Cefdinir—MPO—Vitamin B12 Metabolism—F7—atherosclerosis	0.000851	0.0199	CbGpPWpGaD
Cefdinir—Toxic epidermal necrolysis—Lovastatin—atherosclerosis	0.000843	0.00701	CcSEcCtD
Cefdinir—Jaundice—Rosuvastatin—atherosclerosis	0.00083	0.0069	CcSEcCtD
Cefdinir—Aspartate aminotransferase increased—Ezetimibe—atherosclerosis	0.000827	0.00688	CcSEcCtD
Cefdinir—MPO—Vitamin B12 Metabolism—SCARB1—atherosclerosis	0.000824	0.0193	CbGpPWpGaD
Cefdinir—Purpura—Pravastatin—atherosclerosis	0.000821	0.00683	CcSEcCtD
Cefdinir—Haematuria—Rosuvastatin—atherosclerosis	0.000812	0.00675	CcSEcCtD
Cefdinir—MPO—IL23-mediated signaling events—SOCS3—atherosclerosis	0.00079	0.0185	CbGpPWpGaD
Cefdinir—Toxic epidermal necrolysis—Simvastatin—atherosclerosis	0.000789	0.00656	CcSEcCtD
Cefdinir—MPO—Selenium Micronutrient Network—ALOX5AP—atherosclerosis	0.000761	0.0178	CbGpPWpGaD
Cefdinir—MPO—Vitamin B12 Metabolism—PLAT—atherosclerosis	0.000759	0.0178	CbGpPWpGaD
Cefdinir—SLC22A5—adipose tissue—atherosclerosis	0.000752	0.0137	CbGeAlD
Cefdinir—MPO—IL23-mediated signaling events—IL18—atherosclerosis	0.00072	0.0169	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—LDLR—atherosclerosis	0.000717	0.0168	CbGpPWpGaD
Cefdinir—Stevens-Johnson syndrome—Lovastatin—atherosclerosis	0.000715	0.00595	CcSEcCtD
Cefdinir—Toxic epidermal necrolysis—Pravastatin—atherosclerosis	0.000713	0.00593	CcSEcCtD
Cefdinir—MPO—Vitamin B12 Metabolism—ABCA1—atherosclerosis	0.000694	0.0162	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—F7—atherosclerosis	0.000692	0.0162	CbGpPWpGaD
Cefdinir—Jaundice—Ezetimibe—atherosclerosis	0.00069	0.00574	CcSEcCtD
Cefdinir—MPO—Folate Metabolism—SCARB1—atherosclerosis	0.000671	0.0157	CbGpPWpGaD
Cefdinir—Stevens-Johnson syndrome—Simvastatin—atherosclerosis	0.000669	0.00557	CcSEcCtD
Cefdinir—Jaundice—Simvastatin—atherosclerosis	0.000658	0.00547	CcSEcCtD
Cefdinir—Flatulence—Rosuvastatin—atherosclerosis	0.000656	0.00545	CcSEcCtD
Cefdinir—MPO—Selenium Micronutrient Network—ALOX5—atherosclerosis	0.000647	0.0152	CbGpPWpGaD
Cefdinir—MPO—Vitamin B12 Metabolism—PLG—atherosclerosis	0.000645	0.0151	CbGpPWpGaD
Cefdinir—MPO—Vitamin B12 Metabolism—SOD1—atherosclerosis	0.000618	0.0145	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—PLAT—atherosclerosis	0.000617	0.0145	CbGpPWpGaD
Cefdinir—Erythema multiforme—Lovastatin—atherosclerosis	0.000612	0.00509	CcSEcCtD
Cefdinir—Stevens-Johnson syndrome—Pravastatin—atherosclerosis	0.000605	0.00503	CcSEcCtD
Cefdinir—Stomatitis—Niacin—atherosclerosis	0.000604	0.00502	CcSEcCtD
Cefdinir—Jaundice—Niacin—atherosclerosis	0.000604	0.00502	CcSEcCtD
Cefdinir—Acute coronary syndrome—Pravastatin—atherosclerosis	0.000601	0.005	CcSEcCtD
Cefdinir—Erythema multiforme—Ezetimibe—atherosclerosis	0.000601	0.005	CcSEcCtD
Cefdinir—Myocardial infarction—Pravastatin—atherosclerosis	0.000598	0.00497	CcSEcCtD
Cefdinir—Jaundice—Pravastatin—atherosclerosis	0.000595	0.00495	CcSEcCtD
Cefdinir—Erythema multiforme—Simvastatin—atherosclerosis	0.000573	0.00476	CcSEcCtD
Cefdinir—MPO—Vitamin B12 Metabolism—APOB—atherosclerosis	0.00057	0.0134	CbGpPWpGaD
Cefdinir—MPO—Selenium Micronutrient Network—LDLR—atherosclerosis	0.00057	0.0133	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—ABCA1—atherosclerosis	0.000565	0.0132	CbGpPWpGaD
Cefdinir—Haemoglobin—Niacin—atherosclerosis	0.000559	0.00465	CcSEcCtD
Cefdinir—MPO—Vitamin B12 Metabolism—SOD2—atherosclerosis	0.000557	0.013	CbGpPWpGaD
Cefdinir—MPO—Vitamin B12 Metabolism—CCL5—atherosclerosis	0.000557	0.013	CbGpPWpGaD
Cefdinir—Haemorrhage—Niacin—atherosclerosis	0.000556	0.00463	CcSEcCtD
Cefdinir—Flatulence—Lovastatin—atherosclerosis	0.000556	0.00462	CcSEcCtD
Cefdinir—MPO—Selenium Micronutrient Network—F7—atherosclerosis	0.00055	0.0129	CbGpPWpGaD
Cefdinir—MPO—IL23-mediated signaling events—NOS2—atherosclerosis	0.00055	0.0129	CbGpPWpGaD
Cefdinir—Cefaclor—MPO—atherosclerosis	0.000548	0.225	CrCbGaD
Cefdinir—Flatulence—Ezetimibe—atherosclerosis	0.000545	0.00453	CcSEcCtD
Cefdinir—MPO—Selenium Micronutrient Network—SCARB1—atherosclerosis	0.000533	0.0125	CbGpPWpGaD
Cefdinir—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.000532	0.00442	CcSEcCtD
Cefdinir—SLC22A5—liver—atherosclerosis	0.000527	0.00963	CbGeAlD
Cefdinir—MPO—Folate Metabolism—PLG—atherosclerosis	0.000525	0.0123	CbGpPWpGaD
Cefdinir—Flatulence—Simvastatin—atherosclerosis	0.00052	0.00432	CcSEcCtD
Cefdinir—Erythema multiforme—Pravastatin—atherosclerosis	0.000518	0.00431	CcSEcCtD
Cefdinir—Leukopenia—Lovastatin—atherosclerosis	0.000505	0.0042	CcSEcCtD
Cefdinir—MPO—Folate Metabolism—SOD1—atherosclerosis	0.000503	0.0118	CbGpPWpGaD
Cefdinir—MPO—IL23-mediated signaling events—CCL2—atherosclerosis	0.000496	0.0116	CbGpPWpGaD
Cefdinir—Insomnia—Rosuvastatin—atherosclerosis	0.000491	0.00409	CcSEcCtD
Cefdinir—MPO—Selenium Micronutrient Network—PLAT—atherosclerosis	0.00049	0.0115	CbGpPWpGaD
Cefdinir—MPO—Vitamin B12 Metabolism—MTHFR—atherosclerosis	0.00049	0.0115	CbGpPWpGaD
Cefdinir—Chest pain—Lovastatin—atherosclerosis	0.00048	0.00399	CcSEcCtD
Cefdinir—Dyspepsia—Rosuvastatin—atherosclerosis	0.000478	0.00398	CcSEcCtD
Cefdinir—Hypertension—Ezetimibe—atherosclerosis	0.000477	0.00397	CcSEcCtD
Cefdinir—Flatulence—Niacin—atherosclerosis	0.000477	0.00397	CcSEcCtD
Cefdinir—Leukopenia—Simvastatin—atherosclerosis	0.000472	0.00393	CcSEcCtD
Cefdinir—Chest pain—Ezetimibe—atherosclerosis	0.000471	0.00392	CcSEcCtD
Cefdinir—Flatulence—Pravastatin—atherosclerosis	0.00047	0.00391	CcSEcCtD
Cefdinir—Dry mouth—Lovastatin—atherosclerosis	0.000469	0.00391	CcSEcCtD
Cefdinir—MPO—Vitamin B12 Metabolism—CRP—atherosclerosis	0.000466	0.0109	CbGpPWpGaD
Cefdinir—Constipation—Rosuvastatin—atherosclerosis	0.000464	0.00386	CcSEcCtD
Cefdinir—MPO—Folate Metabolism—APOB—atherosclerosis	0.000464	0.0109	CbGpPWpGaD
Cefdinir—Dry mouth—Ezetimibe—atherosclerosis	0.00046	0.00383	CcSEcCtD
Cefdinir—Anaphylactic shock—Lovastatin—atherosclerosis	0.00046	0.00383	CcSEcCtD
Cefdinir—MPO—Vitamin B12 Metabolism—APOE—atherosclerosis	0.000456	0.0107	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—SOD2—atherosclerosis	0.000453	0.0106	CbGpPWpGaD
Cefdinir—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000451	0.00375	CcSEcCtD
Cefdinir—MPO—Vitamin B12 Metabolism—APOA1—atherosclerosis	0.000451	0.0106	CbGpPWpGaD
Cefdinir—Thrombocytopenia—Lovastatin—atherosclerosis	0.000451	0.00375	CcSEcCtD
Cefdinir—Chest pain—Simvastatin—atherosclerosis	0.000449	0.00373	CcSEcCtD
Cefdinir—MPO—Selenium Micronutrient Network—ABCA1—atherosclerosis	0.000448	0.0105	CbGpPWpGaD
Cefdinir—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000444	0.00369	CcSEcCtD
Cefdinir—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000442	0.00368	CcSEcCtD
Cefdinir—Anorexia—Lovastatin—atherosclerosis	0.000439	0.00365	CcSEcCtD
Cefdinir—Leukopenia—Niacin—atherosclerosis	0.000433	0.00361	CcSEcCtD
Cefdinir—MPO—Folate Metabolism—GPX1—atherosclerosis	0.000432	0.0101	CbGpPWpGaD
Cefdinir—Anaphylactic shock—Simvastatin—atherosclerosis	0.00043	0.00358	CcSEcCtD
Cefdinir—MPO—Vitamin B12 Metabolism—F2—atherosclerosis	0.00043	0.0101	CbGpPWpGaD
Cefdinir—Abdominal pain—Rosuvastatin—atherosclerosis	0.000429	0.00357	CcSEcCtD
Cefdinir—MPO—Vitamin B12 Metabolism—ICAM1—atherosclerosis	0.000429	0.01	CbGpPWpGaD
Cefdinir—Leukopenia—Pravastatin—atherosclerosis	0.000427	0.00355	CcSEcCtD
Cefdinir—Loss of consciousness—Niacin—atherosclerosis	0.000426	0.00354	CcSEcCtD
Cefdinir—MPO—IL23-mediated signaling events—IFNG—atherosclerosis	0.000422	0.00987	CbGpPWpGaD
Cefdinir—Thrombocytopenia—Simvastatin—atherosclerosis	0.000421	0.00351	CcSEcCtD
Cefdinir—MPO—Selenium Micronutrient Network—PLG—atherosclerosis	0.000417	0.00976	CbGpPWpGaD
Cefdinir—Insomnia—Lovastatin—atherosclerosis	0.000416	0.00346	CcSEcCtD
Cefdinir—Hypertension—Pravastatin—atherosclerosis	0.000412	0.00342	CcSEcCtD
Cefdinir—Anorexia—Simvastatin—atherosclerosis	0.00041	0.00341	CcSEcCtD
Cefdinir—Insomnia—Ezetimibe—atherosclerosis	0.000408	0.0034	CcSEcCtD
Cefdinir—Chest pain—Pravastatin—atherosclerosis	0.000406	0.00338	CcSEcCtD
Cefdinir—Dyspepsia—Lovastatin—atherosclerosis	0.000405	0.00337	CcSEcCtD
Cefdinir—Dry mouth—Niacin—atherosclerosis	0.000403	0.00335	CcSEcCtD
Cefdinir—Hypersensitivity—Rosuvastatin—atherosclerosis	0.0004	0.00333	CcSEcCtD
Cefdinir—Decreased appetite—Lovastatin—atherosclerosis	0.0004	0.00333	CcSEcCtD
Cefdinir—MPO—Selenium Micronutrient Network—SOD1—atherosclerosis	0.0004	0.00936	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—MTHFR—atherosclerosis	0.000399	0.00934	CbGpPWpGaD
Cefdinir—Dyspepsia—Ezetimibe—atherosclerosis	0.000397	0.0033	CcSEcCtD
Cefdinir—Anaphylactic shock—Niacin—atherosclerosis	0.000395	0.00329	CcSEcCtD
Cefdinir—Constipation—Lovastatin—atherosclerosis	0.000394	0.00327	CcSEcCtD
Cefdinir—Decreased appetite—Ezetimibe—atherosclerosis	0.000392	0.00326	CcSEcCtD
Cefdinir—MPO—Vitamin B12 Metabolism—INS—atherosclerosis	0.00039	0.00913	CbGpPWpGaD
Cefdinir—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.00039	0.00324	CcSEcCtD
Cefdinir—Asthenia—Rosuvastatin—atherosclerosis	0.00039	0.00324	CcSEcCtD
Cefdinir—Insomnia—Simvastatin—atherosclerosis	0.000389	0.00324	CcSEcCtD
Cefdinir—Anaphylactic shock—Pravastatin—atherosclerosis	0.000389	0.00324	CcSEcCtD
Cefdinir—Shock—Niacin—atherosclerosis	0.000389	0.00323	CcSEcCtD
Cefdinir—Constipation—Ezetimibe—atherosclerosis	0.000386	0.00321	CcSEcCtD
Cefdinir—Pruritus—Rosuvastatin—atherosclerosis	0.000384	0.0032	CcSEcCtD
Cefdinir—MPO—Vitamin B12 Metabolism—CCL2—atherosclerosis	0.000384	0.00898	CbGpPWpGaD
Cefdinir—Thrombocytopenia—Pravastatin—atherosclerosis	0.000381	0.00317	CcSEcCtD
Cefdinir—MPO—Folate Metabolism—CRP—atherosclerosis	0.000379	0.00889	CbGpPWpGaD
Cefdinir—Dyspepsia—Simvastatin—atherosclerosis	0.000379	0.00315	CcSEcCtD
Cefdinir—Anorexia—Niacin—atherosclerosis	0.000377	0.00313	CcSEcCtD
Cefdinir—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000376	0.00313	CcSEcCtD
Cefdinir—MPO—IL23-mediated signaling events—IL1B—atherosclerosis	0.000376	0.00881	CbGpPWpGaD
Cefdinir—Decreased appetite—Simvastatin—atherosclerosis	0.000374	0.00311	CcSEcCtD
Cefdinir—MPO—C-MYB transcription factor network—GSTM1—atherosclerosis	0.000372	0.00871	CbGpPWpGaD
Cefdinir—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000372	0.00309	CcSEcCtD
Cefdinir—Diarrhoea—Rosuvastatin—atherosclerosis	0.000372	0.00309	CcSEcCtD
Cefdinir—Anorexia—Pravastatin—atherosclerosis	0.000371	0.00309	CcSEcCtD
Cefdinir—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000369	0.00307	CcSEcCtD
Cefdinir—MPO—Selenium Micronutrient Network—APOB—atherosclerosis	0.000369	0.00863	CbGpPWpGaD
Cefdinir—Constipation—Simvastatin—atherosclerosis	0.000368	0.00306	CcSEcCtD
Cefdinir—MPO—Folate Metabolism—APOA1—atherosclerosis	0.000367	0.0086	CbGpPWpGaD
Cefdinir—Abdominal pain—Lovastatin—atherosclerosis	0.000364	0.00303	CcSEcCtD
Cefdinir—Body temperature increased—Lovastatin—atherosclerosis	0.000364	0.00303	CcSEcCtD
Cefdinir—MPO—Selenium Micronutrient Network—SOD2—atherosclerosis	0.00036	0.00843	CbGpPWpGaD
Cefdinir—Dizziness—Rosuvastatin—atherosclerosis	0.000359	0.00299	CcSEcCtD
Cefdinir—MPO—Vitamin B12 Metabolism—SERPINE1—atherosclerosis	0.000358	0.00839	CbGpPWpGaD
Cefdinir—Insomnia—Niacin—atherosclerosis	0.000357	0.00297	CcSEcCtD
Cefdinir—MPO—Vitamin B12 Metabolism—ALB—atherosclerosis	0.000357	0.00837	CbGpPWpGaD
Cefdinir—Abdominal pain—Ezetimibe—atherosclerosis	0.000357	0.00297	CcSEcCtD
Cefdinir—Body temperature increased—Ezetimibe—atherosclerosis	0.000357	0.00297	CcSEcCtD
Cefdinir—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000352	0.00293	CcSEcCtD
Cefdinir—Insomnia—Pravastatin—atherosclerosis	0.000352	0.00293	CcSEcCtD
Cefdinir—Somnolence—Niacin—atherosclerosis	0.000351	0.00292	CcSEcCtD
Cefdinir—MPO—IL23-mediated signaling events—NFKB1—atherosclerosis	0.000351	0.00822	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—F2—atherosclerosis	0.00035	0.0082	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—ICAM1—atherosclerosis	0.000349	0.00817	CbGpPWpGaD
Cefdinir—Dyspepsia—Niacin—atherosclerosis	0.000348	0.00289	CcSEcCtD
Cefdinir—Decreased appetite—Niacin—atherosclerosis	0.000344	0.00286	CcSEcCtD
Cefdinir—MPO—Selenium Micronutrient Network—GPX1—atherosclerosis	0.000343	0.00804	CbGpPWpGaD
Cefdinir—Dyspepsia—Pravastatin—atherosclerosis	0.000343	0.00285	CcSEcCtD
Cefdinir—Rash—Rosuvastatin—atherosclerosis	0.000342	0.00285	CcSEcCtD
Cefdinir—Dermatitis—Rosuvastatin—atherosclerosis	0.000342	0.00285	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Niacin—atherosclerosis	0.000341	0.00284	CcSEcCtD
Cefdinir—Body temperature increased—Simvastatin—atherosclerosis	0.00034	0.00283	CcSEcCtD
Cefdinir—Abdominal pain—Simvastatin—atherosclerosis	0.00034	0.00283	CcSEcCtD
Cefdinir—Headache—Rosuvastatin—atherosclerosis	0.00034	0.00283	CcSEcCtD
Cefdinir—Hypersensitivity—Lovastatin—atherosclerosis	0.000339	0.00282	CcSEcCtD
Cefdinir—Decreased appetite—Pravastatin—atherosclerosis	0.000338	0.00281	CcSEcCtD
Cefdinir—Constipation—Pravastatin—atherosclerosis	0.000333	0.00277	CcSEcCtD
Cefdinir—Hypersensitivity—Ezetimibe—atherosclerosis	0.000333	0.00277	CcSEcCtD
Cefdinir—Asthenia—Lovastatin—atherosclerosis	0.00033	0.00275	CcSEcCtD
Cefdinir—MPO—Vitamin B12 Metabolism—IFNG—atherosclerosis	0.000326	0.00764	CbGpPWpGaD
Cefdinir—Pruritus—Lovastatin—atherosclerosis	0.000326	0.00271	CcSEcCtD
Cefdinir—Asthenia—Ezetimibe—atherosclerosis	0.000324	0.00269	CcSEcCtD
Cefdinir—Gastrointestinal pain—Niacin—atherosclerosis	0.000323	0.00269	CcSEcCtD
Cefdinir—Nausea—Rosuvastatin—atherosclerosis	0.000323	0.00268	CcSEcCtD
Cefdinir—Pruritus—Ezetimibe—atherosclerosis	0.000319	0.00266	CcSEcCtD
Cefdinir—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000318	0.00265	CcSEcCtD
Cefdinir—MPO—Folate Metabolism—INS—atherosclerosis	0.000317	0.00743	CbGpPWpGaD
Cefdinir—Hypersensitivity—Simvastatin—atherosclerosis	0.000317	0.00264	CcSEcCtD
Cefdinir—MPO—Selenium Micronutrient Network—MTHFR—atherosclerosis	0.000317	0.00742	CbGpPWpGaD
Cefdinir—MPO—IL23-mediated signaling events—STAT3—atherosclerosis	0.000315	0.00738	CbGpPWpGaD
Cefdinir—Diarrhoea—Lovastatin—atherosclerosis	0.000315	0.00262	CcSEcCtD
Cefdinir—Abdominal pain—Niacin—atherosclerosis	0.000312	0.0026	CcSEcCtD
Cefdinir—Body temperature increased—Niacin—atherosclerosis	0.000312	0.0026	CcSEcCtD
Cefdinir—MPO—Folate Metabolism—CCL2—atherosclerosis	0.000312	0.00731	CbGpPWpGaD
Cefdinir—Asthenia—Simvastatin—atherosclerosis	0.000309	0.00257	CcSEcCtD
Cefdinir—Diarrhoea—Ezetimibe—atherosclerosis	0.000309	0.00257	CcSEcCtD
Cefdinir—Body temperature increased—Pravastatin—atherosclerosis	0.000308	0.00256	CcSEcCtD
Cefdinir—Abdominal pain—Pravastatin—atherosclerosis	0.000308	0.00256	CcSEcCtD
Cefdinir—Pruritus—Simvastatin—atherosclerosis	0.000305	0.00253	CcSEcCtD
Cefdinir—Dizziness—Lovastatin—atherosclerosis	0.000304	0.00253	CcSEcCtD
Cefdinir—MPO—Selenium Micronutrient Network—CRP—atherosclerosis	0.000301	0.00706	CbGpPWpGaD
Cefdinir—Dizziness—Ezetimibe—atherosclerosis	0.000298	0.00248	CcSEcCtD
Cefdinir—Diarrhoea—Simvastatin—atherosclerosis	0.000295	0.00245	CcSEcCtD
Cefdinir—Vomiting—Lovastatin—atherosclerosis	0.000293	0.00243	CcSEcCtD
Cefdinir—MPO—Selenium Micronutrient Network—APOA1—atherosclerosis	0.000292	0.00683	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—SERPINE1—atherosclerosis	0.000291	0.00682	CbGpPWpGaD
Cefdinir—Hypersensitivity—Niacin—atherosclerosis	0.000291	0.00242	CcSEcCtD
Cefdinir—MPO—Vitamin B12 Metabolism—IL1B—atherosclerosis	0.000291	0.00681	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—ALB—atherosclerosis	0.000291	0.00681	CbGpPWpGaD
Cefdinir—Rash—Lovastatin—atherosclerosis	0.00029	0.00241	CcSEcCtD
Cefdinir—Dermatitis—Lovastatin—atherosclerosis	0.00029	0.00241	CcSEcCtD
Cefdinir—Headache—Lovastatin—atherosclerosis	0.000288	0.0024	CcSEcCtD
Cefdinir—Vomiting—Ezetimibe—atherosclerosis	0.000287	0.00239	CcSEcCtD
Cefdinir—Hypersensitivity—Pravastatin—atherosclerosis	0.000287	0.00238	CcSEcCtD
Cefdinir—Dizziness—Simvastatin—atherosclerosis	0.000285	0.00237	CcSEcCtD
Cefdinir—Rash—Ezetimibe—atherosclerosis	0.000285	0.00237	CcSEcCtD
Cefdinir—Dermatitis—Ezetimibe—atherosclerosis	0.000284	0.00237	CcSEcCtD
Cefdinir—Asthenia—Niacin—atherosclerosis	0.000284	0.00236	CcSEcCtD
Cefdinir—Headache—Ezetimibe—atherosclerosis	0.000283	0.00235	CcSEcCtD
Cefdinir—Pruritus—Niacin—atherosclerosis	0.00028	0.00233	CcSEcCtD
Cefdinir—Asthenia—Pravastatin—atherosclerosis	0.000279	0.00232	CcSEcCtD
Cefdinir—MPO—Selenium Micronutrient Network—F2—atherosclerosis	0.000278	0.00651	CbGpPWpGaD
Cefdinir—MPO—Selenium Micronutrient Network—ICAM1—atherosclerosis	0.000277	0.00649	CbGpPWpGaD
Cefdinir—Pruritus—Pravastatin—atherosclerosis	0.000275	0.00229	CcSEcCtD
Cefdinir—Vomiting—Simvastatin—atherosclerosis	0.000274	0.00228	CcSEcCtD
Cefdinir—Nausea—Lovastatin—atherosclerosis	0.000273	0.00227	CcSEcCtD
Cefdinir—MPO—IL23-mediated signaling events—TNF—atherosclerosis	0.000273	0.00639	CbGpPWpGaD
Cefdinir—Rash—Simvastatin—atherosclerosis	0.000271	0.00226	CcSEcCtD
Cefdinir—MPO—Vitamin B12 Metabolism—NFKB1—atherosclerosis	0.000271	0.00636	CbGpPWpGaD
Cefdinir—Dermatitis—Simvastatin—atherosclerosis	0.000271	0.00226	CcSEcCtD
Cefdinir—Diarrhoea—Niacin—atherosclerosis	0.00027	0.00225	CcSEcCtD
Cefdinir—Headache—Simvastatin—atherosclerosis	0.00027	0.00224	CcSEcCtD
Cefdinir—Nausea—Ezetimibe—atherosclerosis	0.000268	0.00223	CcSEcCtD
Cefdinir—Diarrhoea—Pravastatin—atherosclerosis	0.000266	0.00221	CcSEcCtD
Cefdinir—MPO—Folate Metabolism—IFNG—atherosclerosis	0.000265	0.00621	CbGpPWpGaD
Cefdinir—Dizziness—Niacin—atherosclerosis	0.000261	0.00217	CcSEcCtD
Cefdinir—Dizziness—Pravastatin—atherosclerosis	0.000257	0.00214	CcSEcCtD
Cefdinir—Nausea—Simvastatin—atherosclerosis	0.000256	0.00213	CcSEcCtD
Cefdinir—MPO—Selenium Micronutrient Network—INS—atherosclerosis	0.000252	0.0059	CbGpPWpGaD
Cefdinir—Vomiting—Niacin—atherosclerosis	0.000251	0.00209	CcSEcCtD
Cefdinir—Rash—Niacin—atherosclerosis	0.000249	0.00207	CcSEcCtD
Cefdinir—Dermatitis—Niacin—atherosclerosis	0.000249	0.00207	CcSEcCtD
Cefdinir—MPO—Selenium Micronutrient Network—CCL2—atherosclerosis	0.000248	0.00581	CbGpPWpGaD
Cefdinir—Headache—Niacin—atherosclerosis	0.000248	0.00206	CcSEcCtD
Cefdinir—Vomiting—Pravastatin—atherosclerosis	0.000247	0.00206	CcSEcCtD
Cefdinir—Rash—Pravastatin—atherosclerosis	0.000245	0.00204	CcSEcCtD
Cefdinir—Dermatitis—Pravastatin—atherosclerosis	0.000245	0.00204	CcSEcCtD
Cefdinir—Headache—Pravastatin—atherosclerosis	0.000244	0.00203	CcSEcCtD
Cefdinir—MPO—Folate Metabolism—IL1B—atherosclerosis	0.000237	0.00554	CbGpPWpGaD
Cefdinir—Nausea—Niacin—atherosclerosis	0.000235	0.00195	CcSEcCtD
Cefdinir—MPO—Selenium Micronutrient Network—SERPINE1—atherosclerosis	0.000231	0.00542	CbGpPWpGaD
Cefdinir—Nausea—Pravastatin—atherosclerosis	0.000231	0.00192	CcSEcCtD
Cefdinir—MPO—Selenium Micronutrient Network—ALB—atherosclerosis	0.000231	0.00541	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—NFKB1—atherosclerosis	0.000221	0.00517	CbGpPWpGaD
Cefdinir—MPO—IL23-mediated signaling events—IL6—atherosclerosis	0.00022	0.00516	CbGpPWpGaD
Cefdinir—MPO—Vitamin B12 Metabolism—TNF—atherosclerosis	0.000211	0.00494	CbGpPWpGaD
Cefdinir—MPO—Selenium Micronutrient Network—IFNG—atherosclerosis	0.000211	0.00494	CbGpPWpGaD
Cefdinir—MPO—C-MYB transcription factor network—PTGS2—atherosclerosis	0.00021	0.00491	CbGpPWpGaD
Cefdinir—MPO—Selenium Micronutrient Network—PTGS2—atherosclerosis	0.000202	0.00473	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—ABCG4—atherosclerosis	0.000198	0.00464	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—ABCG8—atherosclerosis	0.00019	0.00445	CbGpPWpGaD
Cefdinir—MPO—Selenium Micronutrient Network—IL1B—atherosclerosis	0.000188	0.0044	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—ABCG4—atherosclerosis	0.000184	0.00431	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—ABCG4—atherosclerosis	0.000181	0.00424	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—ABCG8—atherosclerosis	0.000176	0.00413	CbGpPWpGaD
Cefdinir—MPO—Selenium Micronutrient Network—NFKB1—atherosclerosis	0.000175	0.00411	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—ABCG8—atherosclerosis	0.000173	0.00406	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—TNF—atherosclerosis	0.000172	0.00402	CbGpPWpGaD
Cefdinir—MPO—Vitamin B12 Metabolism—IL6—atherosclerosis	0.00017	0.00399	CbGpPWpGaD
Cefdinir—Cefazolin—ALB—atherosclerosis	0.00015	0.0619	CrCbGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—ABCG1—atherosclerosis	0.00015	0.00352	CbGpPWpGaD
Cefdinir—Ceftriaxone—ALB—atherosclerosis	0.000143	0.0587	CrCbGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—ABCG1—atherosclerosis	0.000139	0.00326	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—IL6—atherosclerosis	0.000139	0.00325	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—ABCG1—atherosclerosis	0.000137	0.00321	CbGpPWpGaD
Cefdinir—MPO—Selenium Micronutrient Network—TNF—atherosclerosis	0.000136	0.0032	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—CYP7A1—atherosclerosis	0.000136	0.00319	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—CYP7A1—atherosclerosis	0.000126	0.00296	CbGpPWpGaD
Cefdinir—Cefalotin—ALB—atherosclerosis	0.000125	0.0514	CrCbGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—CYP7A1—atherosclerosis	0.000124	0.00291	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—TRPV1—atherosclerosis	0.000122	0.00287	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—ABCG5—atherosclerosis	0.000118	0.00276	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—TRPV1—atherosclerosis	0.000114	0.00266	CbGpPWpGaD
Cefdinir—Cephalexin—ALB—atherosclerosis	0.000113	0.0467	CrCbGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—TRPV1—atherosclerosis	0.000112	0.00262	CbGpPWpGaD
Cefdinir—MPO—Selenium Micronutrient Network—IL6—atherosclerosis	0.00011	0.00258	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—ABCG5—atherosclerosis	0.000109	0.00256	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—ABCG5—atherosclerosis	0.000108	0.00252	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—CETP—atherosclerosis	8.72e-05	0.00204	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—CETP—atherosclerosis	8.1e-05	0.0019	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—CETP—atherosclerosis	7.96e-05	0.00186	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—PLAT—atherosclerosis	7.69e-05	0.0018	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—PLAT—atherosclerosis	7.13e-05	0.00167	CbGpPWpGaD
Cefdinir—SLC15A2—SLC-mediated transmembrane transport—ALB—atherosclerosis	7.13e-05	0.00167	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—PLAT—atherosclerosis	7.02e-05	0.00164	CbGpPWpGaD
Cefdinir—SLC15A1—SLC-mediated transmembrane transport—ALB—atherosclerosis	6.62e-05	0.00155	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—PLG—atherosclerosis	6.54e-05	0.00153	CbGpPWpGaD
Cefdinir—SLC22A5—SLC-mediated transmembrane transport—ALB—atherosclerosis	6.51e-05	0.00152	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—PLG—atherosclerosis	6.07e-05	0.00142	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—HMOX1—atherosclerosis	6.03e-05	0.00141	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—PLG—atherosclerosis	5.97e-05	0.0014	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—APOB—atherosclerosis	5.78e-05	0.00135	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—HMOX1—atherosclerosis	5.6e-05	0.00131	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—HMOX1—atherosclerosis	5.51e-05	0.00129	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—APOB—atherosclerosis	5.36e-05	0.00126	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—APOB—atherosclerosis	5.27e-05	0.00124	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—PPARA—atherosclerosis	4.87e-05	0.00114	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—APOA1—atherosclerosis	4.57e-05	0.00107	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—PPARA—atherosclerosis	4.52e-05	0.00106	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—PPARA—atherosclerosis	4.45e-05	0.00104	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—APOA1—atherosclerosis	4.24e-05	0.000994	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—APOA1—atherosclerosis	4.17e-05	0.000977	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—ALB—atherosclerosis	3.62e-05	0.000848	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—ALB—atherosclerosis	3.36e-05	0.000787	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—ALB—atherosclerosis	3.31e-05	0.000774	CbGpPWpGaD
